These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35188887)
1. mTOR in the Mechanisms of Atherosclerosis and Cardiovascular Disease. Liu Z; Fan Y; Zhang Z; Fang Y; Cheng X; Yang Q; Liu J; Xie J Discov Med; 2021; 31(164):129-140. PubMed ID: 35188887 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis. Yao X; Yan C; Zhang L; Li Y; Wan Q Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625 [TBL] [Abstract][Full Text] [Related]
3. Role of Mammalian Target of Rapamycin in Atherosclerosis. Cai Z; He Y; Chen Y Curr Mol Med; 2018; 18(4):216-232. PubMed ID: 30259816 [TBL] [Abstract][Full Text] [Related]
4. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway. Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159 [TBL] [Abstract][Full Text] [Related]
5. Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling. Gao S; Xu L; Zhang Y; Yu Q; Li J; Guan H; Wang X; Cheng D; Liu Y; Bai L; Wang R; Fan J; Zhao S; Liu E Cell Physiol Biochem; 2018; 50(5):1740-1753. PubMed ID: 30384378 [TBL] [Abstract][Full Text] [Related]
6. A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy. Liu Y; Huang Q; He M; Chen T; Chu X Acta Biomater; 2024 Mar; 176():356-366. PubMed ID: 38160854 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin. Zhang ZW; Guo RW; Lv JL; Wang XM; Ye JS; Lu NH; Liang X; Yang LX Biochem Biophys Res Commun; 2017 Apr; 486(2):414-422. PubMed ID: 28315335 [TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases. Kaur A; Sharma S Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246 [TBL] [Abstract][Full Text] [Related]
9. An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E⁻/⁻ mice. Peng N; Meng N; Wang S; Zhao F; Zhao J; Su L; Zhang S; Zhang Y; Zhao B; Miao J Sci Rep; 2014 Jul; 4():5519. PubMed ID: 24980430 [TBL] [Abstract][Full Text] [Related]
10. Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases. Samidurai A; Kukreja RC; Das A Oxid Med Cell Longev; 2018; 2018():6141902. PubMed ID: 30305865 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR. Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of mTOR by lentivirus‑mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E‑deficient mice. Wang X; Li L; Li M; Dang X; Wan L; Wang N; Bi X; Gu C; Qiu S; Niu X; Zhu X; Wang L Int J Mol Med; 2013 Nov; 32(5):1215-21. PubMed ID: 24043133 [TBL] [Abstract][Full Text] [Related]
13. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Xiong Y; Yepuri G; Forbiteh M; Yu Y; Montani JP; Yang Z; Ming XF Autophagy; 2014; 10(12):2223-38. PubMed ID: 25484082 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA Chaer mediated Polycomb Repressor Complex 2 (PRC2) activity to promote atherosclerosis through mTOR signaling. Li FP; Ling DQ; Gao LY Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7639-7648. PubMed ID: 31539156 [TBL] [Abstract][Full Text] [Related]
15. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis. Hwang YJ; Park JH; Cho DH J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519 [TBL] [Abstract][Full Text] [Related]
16. Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis. Poznyak AV; Sukhorukov VN; Zhuravlev A; Orekhov NA; Kalmykov V; Orekhov AN Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163076 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-761 inhibits Angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting mammalian target of rapamycin. Cho JR; Lee CY; Lee J; Seo HH; Choi E; Chung N; Kim SM; Hwang KC; Lee S Clin Hemorheol Microcirc; 2015 Sep; 63(1):45-56. PubMed ID: 26444612 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling. Lu YB; Shi C; Yang B; Lu ZF; Wu YL; Zhang RY; He X; Li LM; Hu B; Hu YW; Zheng L; Wang Q Atherosclerosis; 2020 Nov; 312():43-53. PubMed ID: 32971395 [TBL] [Abstract][Full Text] [Related]
20. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of autophagy via inhibiting PI3K/Akt/mTOR pathway in human endothelial cells. Che J; Liang B; Zhang Y; Wang Y; Tang J; Shi G Cardiovasc Pathol; 2017; 31():57-62. PubMed ID: 28985493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]